2016. Cardiovascular safety of tyrosine kinase inhibitors: Putting their “QT-phobia” in perspective. ADMET and DMPK. 4, 3 (Oct. 2016), 212–231. DOI:https://doi.org/10.5599/admet.4.3.295.